Cybin (HELP) Enterprise Value (2021 - 2025)
Cybin (HELP) posted quarterly Enterprise Value of -$195.1 million for Q4 2025, down 100.0% year-on-year from $10339.2 billion in Q4 2024, and down 132.98% on a QoQ basis from -$83.8 million in Q3 2025.
Cybin (HELP) Enterprise Value (2021 - 2025) Analysis & Trends
Cybin (HELP) has reported Enterprise Value for 5 consecutive years, with -$195.1 million the latest figure, recorded in Q4 2025.
- Quarterly Enterprise Value fell 100.0% year-over-year to -$195.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$195.1 million (down 100.0% YoY) and the FY2024 annual result came in at -$155.1 million, changed N/A from the prior year.
- Enterprise Value retreated to -$195.1 million in Q4 2025 per HELP's latest filing, from -$83.8 million in the prior quarter.
- Over the last five years, Enterprise Value for HELP reached as high as -$7.0 million in Q2 2023 and fell as low as -$195.1 million in Q4 2025.
- A 5-year average of -$69.0 million and a median of -$50.4 million in 2021 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value jumped 66.99% — and 2024, when it slumped 1825.32%.
- Year by year, Enterprise Value stood at -$50.2 million in 2021, then soared by 66.99% to -$16.6 million in 2022, then slumped by 72.73% to -$28.6 million in 2023, then tumbled by 240.58% to -$97.6 million in 2024, then tumbled by 100.0% to -$195.1 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$195.1 million, -$83.8 million, and -$97.6 million for Q4 2025, Q3 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -195.13 Mn |
| Sep 30, 2025 | -83.75 Mn |
| Dec 31, 2024 | -97.56 Mn |
| Sep 30, 2024 | -113.12 Mn |
| Jun 30, 2024 | -134.00 Mn |
| Mar 31, 2024 | -155.10 Mn |
| Dec 31, 2023 | -28.65 Mn |
| Sep 30, 2023 | -13.51 Mn |
| Jun 30, 2023 | -6.96 Mn |
| Feb 28, 2023 | -32.01 Mn |
| Dec 31, 2022 | -16.58 Mn |
| Sep 30, 2022 | -22.95 Mn |
| Dec 31, 2021 | -50.24 Mn |
| Sep 30, 2021 | -59.52 Mn |
| Jun 30, 2021 | -44.60 Mn |
| Mar 31, 2021 | -50.59 Mn |